{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:07:47Z","timestamp":1761293267049,"version":"build-2065373602"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11864-025-01354-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:17:55Z","timestamp":1759472275000},"page":"1010-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"26","author":[{"given":"Marina","family":"Tsoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Bel-Ange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Atlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Grozinsky-Glasberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"18","key":"1354_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063\u201372.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000441897","volume":"104","author":"I Huguet","year":"2017","unstructured":"Huguet I, Grossman AB, O\u2019Toole D. Changes in the epidemiology of neuroendocrine tumours. Neuroendocrinology. 2017;104(2):105\u201311.","journal-title":"Neuroendocrinology"},{"issue":"10","key":"1354_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united States. JAMA Oncol. 2017;3(10):1335\u201342.","journal-title":"JAMA Oncol"},{"key":"1354_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112075","author":"N Papadopoulou-Marketou","year":"2024","unstructured":"Papadopoulou-Marketou N, Tsoli M, Chatzellis E, Alexandraki KI, Kaltsas G. Hereditary syndromes associated with pancreatic and lung neuroendocrine tumors. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16112075.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1354_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u201354.","journal-title":"Endocr Pathol"},{"issue":"4","key":"1354_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.annonc.2021.01.003","volume":"32","author":"E Baudin","year":"2021","unstructured":"Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso PL, et al. Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up(\u2606). Ann Oncol. 2021;32(4):439\u201351.","journal-title":"Ann Oncol"},{"issue":"1","key":"1354_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/his.15058","volume":"84","author":"G Vocino Trucco","year":"2024","unstructured":"Vocino Trucco G, Righi L, Volante M, Papotti M. Updates on lung neuroendocrine neoplasm classification. Histopathology. 2024;84(1):67\u201385.","journal-title":"Histopathology"},{"issue":"8","key":"1354_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13318","volume":"35","author":"J Hofland","year":"2023","unstructured":"Hofland J, Falconi M, Christ E, Castano JP, Faggiano A, Lamarca A, et al. European neuroendocrine tumor society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023;35(8).","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"1354_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000443170","volume":"103","author":"B Niederle","year":"2016","unstructured":"Niederle B, Pape UF, Costa F, Gross D, Kelestimur F, Knigge U, et al. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology. 2016;103(2):125\u201338.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1354_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12020-018-1773-3","volume":"64","author":"K Daskalakis","year":"2019","unstructured":"Daskalakis K, Chatzelis E, Tsoli M, Papadopoulou-Marketou N, Dimitriadis GK, Tsolakis AV, et al. Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms. Endocrine. 2019;64(2):384\u201392.","journal-title":"Endocrine"},{"key":"1354_CR11","unstructured":"Tsoli M, Dimitriadis GK, Androulakis II, Kaltsas G, Grossman A et al. Paraneoplastic Syndromes Related to Neuroendocrine Tumors. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, editors. Endotext. South Dartmouth (MA) 2000."},{"key":"1354_CR12","first-page":"281","volume":"7","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA. Cushing\u2019s syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281\u201393.","journal-title":"Clin Epidemiol"},{"issue":"9996","key":"1354_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing\u2019s syndrome. Lancet. 2015;386(9996):913\u201327.","journal-title":"Lancet"},{"issue":"8","key":"1354_CR14","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"1354_CR15","doi-asserted-by":"crossref","unstructured":"Wijewardene AA, Glastras SJ, Learoyd DL, Robinson BG, Tsang VHM. ACTH-secreting medullary thyroid cancer: a case series. Endocrinology, diabetes & metabolism case reports. 2017;2017.","DOI":"10.1530\/EDM-16-0110"},{"key":"1354_CR16","doi-asserted-by":"crossref","unstructured":"Verma R, Lambert A, Katz HH, Benson SJ. Ectopic ACTH-producing large cell neuroendocrine Pancoast tumour presenting as Horner syndrome. BMJ case reports. 2017;2017.","DOI":"10.1136\/bcr-2016-219156"},{"key":"1354_CR17","doi-asserted-by":"crossref","unstructured":"Lawrence L, Zhang P, Choi H, Ahmad U, Arrossi V, Purysko A et al. A unique case of ectopic Cushing\u2019s syndrome from a thymic neuroendocrine carcinoma. Endocrinology, diabetes & metabolism case reports. 2019;2019.","DOI":"10.1530\/EDM-19-0002"},{"issue":"3","key":"1354_CR18","first-page":"e192","volume":"5","author":"M Soundarrajan","year":"2019","unstructured":"Soundarrajan M, Zelada H, Fischer JV, Kopp P. Ectopic adrenocorticotropic hormone syndrome due to metastatic prostate cancer with neuroendocrine differentiation. AACE Clin Case Rep. 2019;5(3):e192-6.","journal-title":"AACE Clin Case Rep"},{"key":"1354_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808199","volume":"13","author":"YX Zhao","year":"2022","unstructured":"Zhao YX, Ma WL, Jiang Y, Zhang GN, Wang LJ, Gong FY, et al. Appendiceal neuroendocrine tumor is a rare cause of ectopic adrenocorticotropic hormone syndrome with cyclic hypercortisolism: a case report and literature review. Front Endocrinol (Lausanne). 2022;13.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1354_CR20","first-page":"48","volume":"87","author":"B Alliet","year":"2024","unstructured":"Alliet B, Severi C, Veekmans T, Cuypers J, Topal H, Deroose CM, et al. Fulminant ectopic cushing\u2019s syndrome caused by metastatic small intestine neuroendocrine tumour - a case report and review of the literature. Acta Gastroenterol Belg. 2024;87(1):48\u201351.","journal-title":"Acta Gastroenterol Belg"},{"issue":"4","key":"1354_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-16-0809","volume":"176","author":"MV Davi","year":"2017","unstructured":"Davi MV, Cosaro E, Piacentini S, Reimondo G, Albiger N, Arnaldi G, et al. Prognostic factors in ectopic cushing\u2019s syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017;176(4):453\u201361.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1354_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13336","volume":"35","author":"T Al-Toubah","year":"2023","unstructured":"Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: a case-series. J Neuroendocrinol. 2023;35(10).","journal-title":"J Neuroendocrinol"},{"key":"1354_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247997","author":"B Hassan","year":"2022","unstructured":"Hassan B, Yazbeck Y, Akiki V, Salti I, Tfayli A. ACTH-secreting metastatic prostate cancer with neuroendocrine differentiation. BMJ Case Rep. 2022. https:\/\/doi.org\/10.1136\/bcr-2021-247997.","journal-title":"BMJ Case Rep"},{"key":"1354_CR24","first-page":"2","volume":"2023","author":"L Foppiani","year":"2023","unstructured":"Foppiani L, Poeta MG, Rutigliani M, Parodi S, Catrambone U, Cavalleri L, et al. Catastrophic ACTH-secreting pheochromocytoma: an uncommon and challenging entity with multifaceted presentation. Endocrinol Diabetes Metab Case Rep. 2023;2023:2.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"1354_CR25","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luaf092","volume":"3","author":"AA Chhachhar","year":"2025","unstructured":"Chhachhar AA, Furqan S, Memon A, Ather H, Islam N. Primary renal neuroendocrine tumor presenting as ectopic ACTH syndrome. JCEM Case Reports. 2025;3(6).","journal-title":"JCEM Case Reports"},{"key":"1354_CR26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-24-0029","author":"D Kishlyansky","year":"2024","unstructured":"Kishlyansky D, Leung AA, Pasieka JL, Mahajan A, Kline GA. Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases. Endocr Relat Cancer. 2024. https:\/\/doi.org\/10.1530\/ERC-24-0029.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1354_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1530\/EJE-15-0968","volume":"174","author":"K Kamp","year":"2016","unstructured":"Kamp K, Alwani RA, Korpershoek E, Franssen GJ, de Herder WW, Feelders RA. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur J Endocrinol. 2016;174(3):271\u201380.","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1002\/cncr.26029","volume":"117","author":"S Ejaz","year":"2011","unstructured":"Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, et al. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the university of Texas MD Anderson cancer center experience. Cancer. 2011;117(19):4381\u20139.","journal-title":"Cancer"},{"issue":"4","key":"1354_CR29","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/EJE-19-0877","volume":"182","author":"J Young","year":"2020","unstructured":"Young J, Haissaguerre M, Viera-Pinto O, Chabre O, Baudin E, Tabarin A. MANAGEMENT OF ENDOCRINE DISEASE: cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol. 2020;182(4):R29-58.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1354_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ecl.2018.01.005","volume":"47","author":"AR Hayes","year":"2018","unstructured":"Hayes AR, Grossman AB. The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging. Endocrinol Metab Clin North Am. 2018;47(2):409\u201325.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"1354_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archinte.1993.00410060054009","volume":"153","author":"L Delisle","year":"1993","unstructured":"Delisle L, Boyer MJ, Warr D, Killinger D, Payne D, Yeoh JL, et al. Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med. 1993;153(6):746\u201352.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1354_CR32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jtho.2019.02.002","volume":"14","author":"P Robelin","year":"2019","unstructured":"Robelin P, Hadoux J, Forestier J, Planchard D, Hervieu V, Berdelou A, et al. Characterization, prognosis, and treatment of patients with metastatic lung carcinoid tumors. J Thorac Oncol. 2019;14(6):993\u20131002.","journal-title":"J Thorac Oncol"},{"issue":"9522","key":"1354_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing\u2019s syndrome. Lancet. 2006;367(9522):1605\u201317.","journal-title":"Lancet"},{"issue":"4","key":"1354_CR34","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11154-021-09660-2","volume":"22","author":"F Guerrero-Perez","year":"2021","unstructured":"Guerrero-Perez F, Peiro I, Marengo AP, Teule A, Ruffinelli JC, Llatjos R, et al. Ectopic cushing\u2019s syndrome due to thymic neuroendocrine tumours: a systematic review. Rev Endocr Metab Disord. 2021;22(4):1041\u201356.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"1354_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-013-0141-6","volume":"47","author":"X Li","year":"2014","unstructured":"Li X, Su J, Zhao L, Wu J, Ding X, Fang F, et al. Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred. Endocrine. 2014;47(1):183\u201390.","journal-title":"Endocrine"},{"issue":"3","key":"1354_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2265.2011.04220.x","volume":"76","author":"WF Simonds","year":"2012","unstructured":"Simonds WF, Varghese S, Marx SJ, Nieman LK. Cushing\u2019s syndrome in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2012;76(3):379\u201386.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"24","key":"1354_CR37","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1056\/NEJM198812153192419","volume":"319","author":"BB Mendonca","year":"1988","unstructured":"Mendonca BB, Arnhold IJ, Nicolau W, Avancini VA, Boise W. Cushing\u2019s syndrome due to ectopic ACTH secretion by bilateral pheochromocytomas in multiple endocrine neoplasia type 2A. N Engl J Med. 1988;319(24):1610\u20131.","journal-title":"N Engl J Med"},{"issue":"7","key":"1354_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/000313480807400714","volume":"74","author":"V Zaydfudim","year":"2008","unstructured":"Zaydfudim V, Stover DG, Caro SW, Phay JE. Presentation of a medullary endocrine neoplasia 2A kindred with cushing\u2019s syndrome. Am Surg. 2008;74(7):659\u201361.","journal-title":"Am Surg"},{"issue":"1","key":"1354_CR39","first-page":"9","volume":"34","author":"E Hatipoglu","year":"2013","unstructured":"Hatipoglu E, Kepicoglu H, Rusen E, Kabasakal L, Gundogdu S, Kadioglu P. Von Hippel Lindau disease with metastatic pancreatic neuroendocrine tumor causing ectopic cushing\u2019s syndrome. Neuro Endocrinol Lett. 2013;34(1):9\u201313.","journal-title":"Neuro Endocrinol Lett"},{"key":"1354_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084041","author":"F Marini","year":"2021","unstructured":"Marini F, Giusti F, Tonelli F, Brandi ML. Pancreatic neuroendocrine neoplasms in multiple endocrine neoplasia type 1. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22084041.","journal-title":"Int J Mol Sci"},{"key":"1354_CR41","doi-asserted-by":"publisher","first-page":"1398436","DOI":"10.3389\/fendo.2024.1398436","volume":"15","author":"JC Riano-Moreno","year":"2024","unstructured":"Riano-Moreno JC, Gonzalez-Clavijo AM, Torres JW, Medina BV, Romero-Rojas AE, Vieda-Celemin I, et al. Case report: comprehensive follow-up of a Colombian family carrying a novel MEN1 variant linked to a rare ACTH-producing pancreatic neuroendocrine carcinoma. Front Endocrinol (Lausanne). 2024;15:1398436.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1354_CR42","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","volume":"109","author":"S Puglisi","year":"2024","unstructured":"Puglisi S, Perini AME, Botto C, Oliva F, Terzolo M. Long-term consequences of Cushing syndrome: a systematic literature review. J Clin Endocrinol Metab. 2024;109(3):e901-19.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1354_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11102-018-0894-2","volume":"21","author":"M Araujo Castro","year":"2018","unstructured":"Araujo Castro M, Marazuela Azpiroz M. Two types of ectopic Cushing syndrome or a continuum? Review. Pituitary. 2018;21(5):535\u201344.","journal-title":"Pituitary"},{"issue":"3","key":"1354_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-11-0949","volume":"166","author":"ST Sharma","year":"2012","unstructured":"Sharma ST, Nieman LK. Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing\u2019s syndrome caused by ectopic ACTH secretion. Eur J Endocrinol. 2012;166(3):531\u20136.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1354_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1365-2265.1997.1210935.x","volume":"46","author":"G Liebowitz","year":"1997","unstructured":"Liebowitz G, White A, Hadani M, Gross DJ. Fluctuating hyper-hypocortisolaemia: a variant of cushing\u2019s syndrome. Clin Endocrinol. 1997;46(6):759\u201363.","journal-title":"Clin Endocrinol"},{"key":"1354_CR46","doi-asserted-by":"crossref","unstructured":"Wang K, Liu F, Wu C, Liu Y, Qi L, Yang X, et al. Cyclic Cushing's syndrome caused by neuroendocrine tumor: a case report. Endocr J. 2019;66(2):175-80.","DOI":"10.1507\/endocrj.EJ18-0168"},{"key":"1354_CR47","doi-asserted-by":"crossref","unstructured":"Tabarin A, Assie G, Barat P, Bonnet F, Bonneville JF, Borson-Chazot F, et al. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome. Ann Endocrinol (Paris). 2022;83(2):119-41.","DOI":"10.1016\/j.ando.2022.02.001"},{"issue":"12","key":"1354_CR48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1354_CR49","doi-asserted-by":"crossref","unstructured":"Reincke M, Fleseriu M. Cushing Syndrome: A Review. JAMA. 2023;330(2):170-81.","DOI":"10.1001\/jama.2023.11305"},{"key":"1354_CR50","doi-asserted-by":"crossref","unstructured":"Ragnarsson O, Juhlin CC, Torpy DJ, Falhammar H. A clinical perspective on ectopic Cushing's syndrome. Trends Endocrinol Metab. 2024;35(4):347-60.","DOI":"10.1016\/j.tem.2023.12.003"},{"key":"1354_CR51","doi-asserted-by":"crossref","unstructured":"Nieman LK, Castinetti F, Newell-Price J, Valassi E, Drouin J, Takahashi Y, et al. Cushing syndrome. Nat Rev Dis Primers. 2025;11(1):4.","DOI":"10.1038\/s41572-024-00588-w"},{"issue":"1","key":"1354_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0889-8529(05)70124-9","volume":"29","author":"DC Aron","year":"2000","unstructured":"Aron DC, Howlett TA. Pituitary incidentalomas. Endocrinol Metab Clin North Am. 2000;29(1):205\u201321.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"1354_CR53","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593\u2013602.","journal-title":"J Clin Endocrinol Metab"},{"key":"1354_CR54","unstructured":"Juszczak A, Morris D, Grossman A et al. Cushing\u2019s Syndrome. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, editors. Endotext. South Dartmouth (MA) 2000."},{"issue":"3","key":"1354_CR55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology. 2017;105(3):212\u201344.","journal-title":"Neuroendocrinology"},{"key":"1354_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.958442","volume":"13","author":"D Ryzhkova","year":"2022","unstructured":"Ryzhkova D, Mitrofanova L, Tsoy U, Grineva E, Schlyakhto E. Dual-tracer PET\/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: a case report and literature review. Front Endocrinol (Lausanne). 2022;13.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1354_CR57","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1210\/JC.2015-1589","volume":"100","author":"AM Isidori","year":"2015","unstructured":"Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, et al. Conventional and nuclear medicine imaging in ectopic Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab. 2015;100(9):3231\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1354_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11102-019-00972-w","volume":"22","author":"E Varlamov","year":"2019","unstructured":"Varlamov E, Hinojosa-Amaya JM, Stack M, Fleseriu M. Diagnostic utility of Gallium-68-somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience. Pituitary. 2019;22(5):445\u201355.","journal-title":"Pituitary"},{"issue":"8","key":"1354_CR59","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1354_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3803\/EnM.2024.501","volume":"40","author":"L Guignat","year":"2025","unstructured":"Guignat L, Bertherat J. Medical treatment of cushing\u2019s syndrome. Endocrinol Metab (Seoul). 2025;40(1):26\u201338.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"1354_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000461583","volume":"105","author":"G Kaltsas","year":"2017","unstructured":"Kaltsas G, Caplin M, Davies P, Ferone D, Garcia-Carbonero R, Grozinsky-Glasberg S, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. Neuroendocrinology. 2017;105(3):245\u201354.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1354_CR62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172\u201385.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"1354_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejso.2018.03.012","volume":"45","author":"FM Laskaratos","year":"2019","unstructured":"Laskaratos FM, Caplin M. Treatment challenges in and outside a network setting: gastrointestinal neuroendocrine tumours. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2019;45(1):52\u20139.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"1","key":"1354_CR64","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luac008","volume":"1","author":"TW Wong","year":"2023","unstructured":"Wong TW. Long-term treatment with metyrapone in a man with ectopic Cushing syndrome. JCEM Case Reports. 2023;1(1).","journal-title":"JCEM Case Reports"},{"issue":"5","key":"1354_CR65","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/EJE-17-0886","volume":"178","author":"J Young","year":"2018","unstructured":"Young J, Bertherat J, Vantyghem MC, Chabre O, Senoussi S, Chadarevian R, et al. Hepatic safety of ketoconazole in Cushing\u2019s syndrome: results of a compassionate use programme in France. Eur J Endocrinol. 2018;178(5):447\u201358.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1354_CR66","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1530\/EJE-18-0694","volume":"179","author":"M Ollivier","year":"2018","unstructured":"Ollivier M, Haissaguerre M, Ferriere A, Tabarin A. Should we avoid using ketoconazole in patients with severe cushing\u2019s syndrome and increased levels of liver enzymes? Eur J Endocrinol. 2018;179(5):L1-2.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1354_CR67","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11102-022-01263-7","volume":"25","author":"R Pivonello","year":"2022","unstructured":"Pivonello R, Zacharieva S, Elenkova A, Toth M, Shimon I, Stigliano A, et al. Levoketoconazole in the treatment of patients with endogenous cushing\u2019s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS). Pituitary. 2022;25(6):911\u201326.","journal-title":"Pituitary"},{"issue":"11","key":"1354_CR68","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2213-8587(19)30313-4","volume":"7","author":"M Fleseriu","year":"2019","unstructured":"Fleseriu M, Pivonello R, Elenkova A, Salvatori R, Auchus RJ, Feelders RA, et al. Efficacy and safety of levoketoconazole in the treatment of endogenous cushing\u2019s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet Diabetes Endocrinol. 2019;7(11):855\u201365.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"1354_CR69","doi-asserted-by":"publisher","first-page":"e2882","DOI":"10.1210\/clinem\/dgac178","volume":"107","author":"M Gadelha","year":"2022","unstructured":"Gadelha M, Bex M, Feelders RA, Heaney AP, Auchus RJ, Gilis-Januszewska A, et al. Randomized trial of Osilodrostat for the treatment of Cushing disease. J Clin Endocrinol Metab. 2022;107(7):e2882-95.","journal-title":"J Clin Endocrinol Metab"},{"key":"1354_CR70","doi-asserted-by":"crossref","unstructured":"Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, et al. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol. 2020;8(9):748-61.","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"1354_CR71","doi-asserted-by":"crossref","unstructured":"Dormoy A, Haissaguerre M, Vitellius G, Do Cao C, Geslot A, Drui D, et al. Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France. J Clin Endocrinol Metab. 2023;108(6):1475-87.","DOI":"10.1210\/clinem\/dgac691"},{"issue":"1","key":"1354_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1210\/jc.2012-2851","volume":"98","author":"V Chortis","year":"2013","unstructured":"Chortis V, Taylor AE, Schneider P, Tomlinson JW, Hughes BA, O\u2019Neil DM, et al. Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement. J Clin Endocrinol Metab. 2013;98(1):161\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1354_CR73","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/jc.2009-1317","volume":"95","author":"B Donadille","year":"2010","unstructured":"Donadille B, Groussin L, Waintrop C, Abbas H, Tenenbaum F, Dugue MA, et al. Management of cushing\u2019s syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para\u2019-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. J Clin Endocrinol Metab. 2010;95(2):537\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"1354_CR74","doi-asserted-by":"crossref","unstructured":"Baudry C, Coste J, Bou Khalil R, Silvera S, Guignat L, Guibourdenche J, et al. Efficiency and tolerance of mitotane in cushing\u2019s disease in 76 patients from a single center. Eur J Endocrinol. 2012;167(4):473\u201381.","DOI":"10.1530\/EJE-12-0358"},{"issue":"9","key":"1354_CR75","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1210\/jc.2011-0536","volume":"96","author":"P Kamenicky","year":"2011","unstructured":"Kamenicky P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent cushing\u2019s syndrome. J Clin Endocrinol Metab. 2011;96(9):2796\u2013804.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1354_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/js.2018-00269","volume":"3","author":"TB Carroll","year":"2019","unstructured":"Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, et al. Continuous etomidate infusion for the management of severe Cushing syndrome: validation of a standard protocol. J Endocr Soc. 2019;3(1):1\u201312.","journal-title":"J Endocr Soc"},{"issue":"4","key":"1354_CR77","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf039","volume":"9","author":"DT Muthukuda","year":"2025","unstructured":"Muthukuda DT, Liyanaarachchi KD, Jayawickreme KP, Mahesh PKB, Ruwanga VGD, Kumar S, et al. Etomidate in severe Cushing syndrome: a systematic review. J Endocr Soc. 2025;9(4).","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"1354_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000314224","volume":"92","author":"F Castinetti","year":"2010","unstructured":"Castinetti F, Conte-Devolx B, Brue T. Medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor antagonists and mifepristone. Neuroendocrinology. 2010;92(Suppl 1):125\u201330.","journal-title":"Neuroendocrinology"},{"key":"1354_CR79","doi-asserted-by":"publisher","DOI":"10.1177\/2042018818804698","volume":"10","author":"M Tsoli","year":"2019","unstructured":"Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G. Current best practice in the management of neuroendocrine tumors. Ther Adv Endocrinol Metab. 2019;10.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7","key":"1354_CR80","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","volume":"32","author":"AC Dingemans","year":"2021","unstructured":"Dingemans AC, Fruh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, et al. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up(\u2606). Ann Oncol. 2021;32(7):839\u201353.","journal-title":"Ann Oncol"},{"key":"1354_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1177125","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Li C, Qi X, Yu L, Lin L. Management of small cell lung cancer complicated with paraneoplastic cushing\u2019s syndrome: a systematic literature review. Front Endocrinol (Lausanne). 2023;14.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1294","key":"1354_CR82","first-page":"92","volume":"122","author":"H Falhammar","year":"2009","unstructured":"Falhammar H. Cyclic ectopic Cushing\u2019s syndrome and somatostatin analogue treatment. N Z Med J. 2009;122(1294):92\u20135.","journal-title":"N Z Med J"},{"issue":"4","key":"1354_CR83","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.1992.tb01461.x","volume":"36","author":"NW Cheung","year":"1992","unstructured":"Cheung NW, Boyages SC. Failure of somatostatin analogue to control Cushing\u2019s syndrome in two cases of ACTH-producing carcinoid tumours. Clin Endocrinol (Oxf). 1992;36(4):361\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1354_CR84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1507\/endocrj.EJ22-0560","volume":"70","author":"ZA Efstathiadou","year":"2023","unstructured":"Efstathiadou ZA, Divaris E, Michou A, Kyriakopoulos G, Kita MD. Complete and sustained remission of hypercortisolism with pasireotide treatment of an adrenocorticotropic hormone (ACTH)-secreting thoracic neuroendocrine tumor: an n-of-1 trial. Endocr J. 2023;70(2):229\u201332.","journal-title":"Endocr J"},{"key":"1354_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6283706","volume":"2022","author":"D Zhang","year":"2022","unstructured":"Zhang D, Lu L, Zhu HJ, Xiao Y, Han XL, Du SD, et al. Somatostatin treatment for ectopic ACTH syndrome due to pancreatic neuroendocrine tumors: review of the literature. Int J Endocrinol. 2022;2022.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"1354_CR86","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2967\/jnumed.123.265894","volume":"65","author":"L Friebe","year":"2024","unstructured":"Friebe L, Freitag MT, Braun M, Nicolas G, Bauman A, Bushnell D, et al. Peptide receptor radionuclide therapy is effective for clinical control of symptomatic metastatic insulinoma: a long-term retrospective analysis. J Nucl Med. 2024;65(2):228\u201335.","journal-title":"J Nucl Med"},{"issue":"9","key":"1354_CR87","doi-asserted-by":"publisher","first-page":"e3665","DOI":"10.1210\/clinem\/dgab289","volume":"106","author":"WT Zandee","year":"2021","unstructured":"Zandee WT, Brabander T, Blazevic A, Minczeles NS, Feelders RA, de Herder WW, et al. Peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome. J Clin Endocrinol Metab. 2021;106(9):e3665-72.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1354_CR88","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1097\/RLU.0000000000002834","volume":"45","author":"J Zhang","year":"2020","unstructured":"Zhang J, Kulkarni HR, Baum RP. Ectopic Corticotropin-Releasing Hormone-Secreting pancreatic neuroendocrine tumor: excellent response of liver metastases to peptide receptor radionuclide therapy as demonstrated by 68Ga-DOTATOC and 18F-FDG PET\/CT imaging. Clin Nucl Med. 2020;45(2):e125-7.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"1354_CR89","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000543177","volume":"18","author":"T Koizumi","year":"2025","unstructured":"Koizumi T, Sato A, Kitajima K, Yamazaki M, Kanazawa S, Notake T, et al. An ACTH-producing neuroendocrine tumor: clinical course of multidisciplinary therapy including peptide receptor radionuclide therapy - a case report. Case Rep Oncol. 2025;18(1):181\u20139.","journal-title":"Case Rep Oncol"},{"issue":"1","key":"1354_CR90","doi-asserted-by":"publisher","first-page":"e240013","DOI":"10.1530\/EO-24-0013","volume":"4","author":"E Boehm","year":"2024","unstructured":"Boehm E, Hung T, Akhurst T, Alipour R, Chiang C, Hicks RJ, et al. Peptide receptor radionuclide therapy for ectopic Cushing\u2019s syndrome caused by metastatic neuroendocrine neoplasms. Endocrine Oncology. 2024;4(1):e240013. https:\/\/doi.org\/10.1530\/EO-24-0013.","journal-title":"Endocrine Oncology"},{"issue":"6","key":"1354_CR91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMc1301428","volume":"369","author":"C Baudry","year":"2013","unstructured":"Baudry C, Paepegaey AC, Groussin L. Reversal of Cushing\u2019s syndrome by Vandetanib in medullary thyroid carcinoma. N Engl J Med. 2013;369(6):584\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"1354_CR92","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1089\/thy.2013.0571","volume":"24","author":"R Barroso-Sousa","year":"2014","unstructured":"Barroso-Sousa R, Lerario AM, Evangelista J, Papadia C, Lourenco DM Jr., Lin CS, et al. Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome. Thyroid. 2014;24(6):1062\u20136.","journal-title":"Thyroid"},{"issue":"1","key":"1354_CR93","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12020-014-0352-5","volume":"49","author":"P Marques","year":"2015","unstructured":"Marques P, Vieira Mda S, Bugalho MJ. Ectopic Cushing in a patient with medullary thyroid carcinoma: hypercortisolism control and tumor reduction with Sunitinib. Endocrine. 2015;49(1):290\u20132.","journal-title":"Endocrine"},{"key":"1354_CR94","doi-asserted-by":"crossref","unstructured":"Bseiso H, Lev-Cohain N, Gross DJ, Grozinsky-Glasberg S. Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing\u2019s syndrome in a medullary thyroid carcinoma patient. Endocrinol Diabetes Metab Case Rep. 2016;2016.","DOI":"10.1530\/EDM-16-0082"},{"key":"1354_CR95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1472-6823-14-70","volume":"14","author":"SP Rajeev","year":"2014","unstructured":"Rajeev SP, McDougall S, Terlizzo M, Palmer D, Daousi C, Cuthbertson DJ. Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing cushing\u2019s syndrome: treatment response with chemotherapy. BMC Endocr Disord. 2014;14:70.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"1354_CR96","doi-asserted-by":"publisher","first-page":"E862","DOI":"10.1210\/jc.2013-4359","volume":"99","author":"SM Corsello","year":"2014","unstructured":"Corsello SM, Senes P, Iezzi R, Rufini V, Congedo MT, Paragliola RM, et al. Cushing\u2019s syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radiofrequency ablation (RFA). J Clin Endocrinol Metab. 2014;99(5):E862-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1354_CR97","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1507\/endocrj.K09E-179","volume":"57","author":"T Kondo","year":"2010","unstructured":"Kondo T, Matsuyama R, Ashihara H, Matsuo Y, Sasaki K, Goto R, et al. A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases. Endocr J. 2010;57(3):229\u201336.","journal-title":"Endocr J"},{"issue":"4","key":"1354_CR98","doi-asserted-by":"publisher","first-page":"M23","DOI":"10.1530\/EJE-15-0265","volume":"173","author":"M Reincke","year":"2015","unstructured":"Reincke M, Ritzel K, Osswald A, Berr C, Stalla G, Hallfeldt K, et al. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent cushing\u2019s syndrome. Eur J Endocrinol. 2015;173(4):M23-32.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1354_CR99","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/ERC-15-0541","volume":"23","author":"C Guerin","year":"2016","unstructured":"Guerin C, Taieb D, Treglia G, Brue T, Lacroix A, Sebag F, et al. Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism? Endocr Relat Cancer. 2016;23(2):R131-42.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1354_CR100","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/jc.2005-1542","volume":"91","author":"AM Isidori","year":"2006","unstructured":"Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91(2):371\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1354_CR101","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.surg.2022.03.014","volume":"172","author":"JP Landry","year":"2022","unstructured":"Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, et al. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022;172(2):559\u201366.","journal-title":"Surgery"},{"issue":"10","key":"1354_CR102","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1245\/s10434-020-08451-4","volume":"27","author":"T Szabo Yamashita","year":"2020","unstructured":"Szabo Yamashita T, Sada A, Bancos I, Young WF, Dy BM, Farley DR, et al. Bilateral adrenalectomy: differences between Cushing disease and ectopic ACTH-producing tumors. Ann Surg Oncol. 2020;27(10):3851\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1354_CR103","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","volume":"157","author":"L Yip","year":"2022","unstructured":"Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, et al. American association of endocrine surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022;157(10):870\u20137.","journal-title":"JAMA Surg"},{"issue":"2","key":"1354_CR104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-18-0212","volume":"179","author":"A Osswald","year":"2018","unstructured":"Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, et al. Surviving ectopic Cushing\u2019s syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing\u2019s disease during long-term follow-up. Eur J Endocrinol. 2018;179(2):109\u201316.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1354_CR105","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/JTO.0000000000000116","volume":"9","author":"H Nagy-Mignotte","year":"2014","unstructured":"Nagy-Mignotte H, Shestaeva O, Vignoud L, Guillem P, Ruckly S, Chabre O, et al. Prognostic impact of paraneoplastic cushing\u2019s syndrome in small-cell lung cancer. J Thorac Oncol. 2014;9(4):497\u2013505.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"1354_CR106","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cen.14617","volume":"96","author":"VF Koehler","year":"2022","unstructured":"Koehler VF, Fuss CT, Berr CM, Frank-Raue K, Raue F, Hoster E, et al. Medullary thyroid cancer with ectopic cushing\u2019s syndrome: a multicentre case series. Clin Endocrinol (Oxf). 2022;96(6):847\u201356.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1354_CR107","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s42000-019-00163-z","volume":"19","author":"I Lase","year":"2020","unstructured":"Lase I, Strele I, Gronberg M, Kozlovacki G, Welin S, Janson ET. Multiple hormone secretion may indicate worse prognosis in patients with ectopic cushing\u2019s syndrome. Hormones (Athens). 2020;19(3):351\u201360.","journal-title":"Hormones (Athens)"},{"issue":"1","key":"1354_CR108","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luac035","volume":"1","author":"G Smushkin","year":"2023","unstructured":"Smushkin G, Phillips R, Chausse G. The elusive neuroendocrine tumor: finding the ectopic ACTH source 16 years after the diagnosis of Cushing syndrome. JCEM Case Reports. 2023;1(1).","journal-title":"JCEM Case Reports"},{"issue":"10418","key":"1354_CR109","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M. Cushing\u2019s syndrome. Lancet. 2023;402(10418):2237\u201352.","journal-title":"Lancet"},{"issue":"4","key":"1354_CR110","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40265-016-0539-6","volume":"76","author":"KI Alexandraki","year":"2016","unstructured":"Alexandraki KI, Grossman AB. Therapeutic strategies for the treatment of severe Cushing\u2019s syndrome. Drugs. 2016;76(4):447\u201358.","journal-title":"Drugs"},{"issue":"4","key":"1354_CR111","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf027","volume":"9","author":"M Fleseriu","year":"2025","unstructured":"Fleseriu M, Auchus RJ, Bancos I, Biller BMK. Osilodrostat treatment for adrenal and ectopic Cushing syndrome: integration of clinical studies with case presentations. J Endocr Soc. 2025;9(4).","journal-title":"J Endocr Soc"},{"issue":"3","key":"1354_CR112","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/phar.1202","volume":"33","author":"FH Morgan","year":"2013","unstructured":"Morgan FH, Laufgraben MJ. Mifepristone for management of Cushing\u2019s syndrome. Pharmacotherapy. 2013;33(3):319\u201329.","journal-title":"Pharmacotherapy"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01354-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-025-01354-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01354-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:03:16Z","timestamp":1761292996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-025-01354-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":112,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s11864-025-01354-0","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"type":"print","value":"1527-2729"},{"type":"electronic","value":"1534-6277"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}